Targovax ASA logo

TRVX - Targovax ASA News Story

NOK6.36 0.0  0.3%

Last Trade - 12:18pm

Sector
Healthcare
Size
Micro Cap
Market Cap £41.6m
Enterprise Value £35.8m
Revenue £221k
Position in Universe 1021st / 1792

BRIEF-Targovax: Presentation Of Pre-Clinical Data From Next Generation ONCOS At AACR Virtual Annual Conference

Wed 24th June, 2020 6:15am
June 24 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ANNOUNCES PRESENTATION OF PRE-CLINICAL DATA FROM
NEXT
GENERATION ONCOS AT AACR VIRTUAL ANNUAL CONFERENCE
    * PRE-CLINICAL IN VITRO AND IN VIVO FINDINGS DEMONSTRATED
THAT
BOTH ONCOS-210 & ONCOS-212 HAVE ANTI-CANCER PROPERTIES AND THAT
DOUBLE TRANSGENES ACT SYNERGISTICALLY

Source text for Eikon:  ID:nWkr23CDWw 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.